Clinical and radiological assessment of 100 patients (97 female) with primary
Sjiogren's syndrome was performed within six months of diagnosis in conjunction with spirometry and measurement of transfer factor for carbon monoxide (TLCO). This was repeated in an unselected subgroup of 30 patients after a mean interval of four years. On initial assessment, 43 patients had symptoms of lung disease and 10 had related physical signs; the chest radiograph was abnormal in five. There was a significant reduction (more than 2 standardised residuals) in forced expiratory volume in one second (FEVy), vital capacity (VC), and TLCO in 14, 12, and 10 patients, 24 patients overall having a significant reduction in one or more of these measures. There was a strong relation between reduction in lung function and both pulmonary symptoms and a lip biopsy specimen positive for Sjogren's syndrome. Lung function at the initial assessment in the 30 patients who were restudied was almost identical to that of the group as a whole. Seventeen now had symptoms and nine had related physical signs. The recorded. Chest radiography and lung function tests were then repeated. Investigations were repeated in the other 70 patients only when they were thought to be clinically indicated.
STATISTICAL ANALYSIS
The method of standardised residuals (SR) was used to assess baseline pulmonary function and to express change with time. Analysis of variance was used to assess the relation between lung function and other variables (the presence or absence of lip biopsy specimens positive for Sjogren's syndrome, anti-Ro antibody, pulmonary symptoms, and smoking). The two sample t test was used to compare baseline values between the group of patients who were followed and those who were not. The paired t test was used to assess change in lung function with time.
Results
The mean age at diagnosis of our 100 patients was 48 (range 15- There was a strong relation between the presence of pulmonary symptoms and a reduction in FEV, and VC (p < 0-001); symptoms were related less closely to low transfer factor (p < 0 05). Patients with a lip biopsy specimen positive for Sjogren's syndrome had a lower FEV, and VC (p < 0.01). The presence of anti-Ro antibody was related to these measures less closely (p < 0-05) We did not detect a significant influence of smoking on lung function, possibly because of the relatively few smokers.
FINDINGS AT REVIEW
The 30 patients who had lung function tests repeated after a mean of four years had a median age of 53 years at diagnosis and included only one man. No differences were found between this group and the other 70 patients at the initial examination with respect to pulmonary symptoms, smoking, lip biopsy positivity, anti-Ro antibody, or baseline lung function.
Clinical and radiological Two patients had stopped smoking during the follow up period, leaving three current smokers in-this group. Four patients developed dyspnoea during follow up, so that 17 patients now reported pulmonary symptoms. Physical signs of chest disease had been detected initially in four patients but were noted in nine patients at review. Bilateral fine crackles were present in all nine, and one had features of a pleural effusion. The chest radiograph, initially abnormal in two patients, had became abnormal in a further two during the follow up period. All showed evidence of alveolitis, with associated persistent pleural effusions in one patient. Kelly Of the other 70 patients who remained under review but did not routinely undergo repeat investigation, one died from an adenocarcinoma of the lung and another required cytotoxic drugs for upper airway obstruction. '3 None of our patients has developed pulmonary lymphoma or pulmonary vasculitis during follow up.
Discussion
Over 40% of our patients had pulmonary symptoms at presentation, though physical signs and radiographic abnormalities were rarely detected at this stage. Almost one quarter of our patients had a significant reduction in lung function on initial assessment and these invariably had symptoms.
Several specific pulmonary complications have been reported in patients with primary Sjogren's syndrome, including pulmonary lymphoma and pseudolymphoma,14 atelectasis and bronchiectasis,3 8 pulmonary hypertension,15 and pulmonary vasculitis."6 We did not identify any of these problems in our 100 patients and, although a few individuals developed infective bronchitis, this was a recurrent problem in only one patient.13 None the less, we did observe a high incidence of pulmonary symptoms and this is in keeping with many previous reports. 18 In our series dyspnoea and cough were more frequent than either wheeze or chest pain, suggesting that the lesions did not usually lie within the major airways or the pleural spaces.
Whether an obstructive or a restrictive pattern of abnormality predominates according to pulmonary function tests is debated.'" Our investigations were insufficiently sensitive to detect minor degrees of small airways obstruction, but we did not find a high incidence of airways obstruction ofclinical relevance. 
